KT
Kriya Therapeutics, Inc.
SEC filingBiotechnology · Morrisville, NC
Amount raised$320.8Msold at filing
Total offering$320.8M
Investors in the raise10count reported to the SEC
FiledSep 10, 2025first sale Jul 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Neelaksh VarshneyDirector
Michele StoneExecutive Officer
Ilan OrenDirector
Saira RamasastryDirector
Ryan GallagherDirector
Keith ManchesterDirector
Katherine EadeExecutive Officer
James MomtazeeDirector
Akshay RaiDirector
Shankar RamaswamyExecutive Officer, Director
Curt HerbertsExecutive Officer
Britt PettyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.